Breast Cancer News

CPRIT awards $13M for prevention, research, recruitmentAug 18, 2017
Researchers in the NCI-designated Dan L Duncan Comprehensive Cancer Center have received $13,107,956 from CPRIT for six new grants.
Annual Metastatic Breast Cancer Conference seeks abstractsMay 22, 2017
The Metastatic Breast Cancer Conference is currently seeking abstracts for consideration at the annual conference on Oct. 12 – 13, 2017 at Baylor College of Medicine.
Avon grant supports breast care services for underservedMay 8, 2017
Following the annual Avon 39 walk, the Avon Foundation for Women presented Baylor with a grant for $100,000 to support the Lester and Sue Smith Breast Center’s Pink 4 Life project.
New technique tests therapies for breast cancer metastasis Apr 21, 2017
A new laboratory technique can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone.
Novel approach can reveal better breast cancer treatmentsMar 28, 2017
Researchers have developed a new way to approach breast cancer treatment by seeking to neutralize specific biological growth drivers.
Scalp cooling effective in reducing hair loss during chemoFeb 14, 2017
Dr. Julie Nangia reports the results of her research studying the effectiveness of scalp cooling therapy in reducing hair loss in women undergoing chemotherapy.
Breast cancer researchers receive $900,000 to support study of treatment resistance, drug efficacyDec 28, 2016
Dr. Meghashyam Kavuri and Dr. Xi Chen have been awarded grants from the Susan G. Komen Foundation to support their breast cancer research.
Scalp-cooling device cuts hair loss in breast cancer patients undergoing chemotherapyDec 9, 2016
A scalp cooling cap has been shown to effective in reducing hair loss in breast cancer patients undergoing chemotherapy.
Promising results shown from combination therapy in HER2-positive and hormone receptor-positive metastatic or local advanced breast cancerDec 8, 2016
A new study reveals the efficacy and safety of treating HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer with pertuzumab in combination with trastuzumab, along with an aromatase inhibitor.
NSABP B52 trial shows estrogen deprivation in neoadjuvant chemotherapy breast cancer treatment is not antagonistic to pathologic complete responseDec 8, 2016
Research by Dr. Mothaffar F. Rimawi he finds that adding an aromatase inhibitor to presurgery breast cancer treatment did not significantly increase or decrease the percentage of patients who experienced a pathologic complete response.